Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0,28%
1 085,81
+3,01
+0,28%
—1 082,801 079,311 090,181 079,31——
SIXC
Communications
SIXC
Communications
SIXC
+0,65%
607,69
+3,92
+0,65%
—603,77603,77611,65602,09——
SIXE
Energy
SIXE
Energy
SIXE
-1,55%
1 192,38
-18,81
-1,55%
—1 211,191 203,051 203,481 182,72——
SIXI
Industrials
SIXI
Industrials
SIXI
+0,02%
1 756,39
+0,40
+0,02%
—1 755,991 759,061 761,741 747,23——
SIXM
Financials
SIXM
Financials
SIXM
-0,82%
633,27
-5,24
-0,82%
—638,51637,93640,10631,89——
SIXR
Staples
SIXR
Staples
SIXR
+1,12%
852,42
+9,46
+1,12%
—842,96843,54858,44843,54——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,22%
218,79
-0,49
-0,22%
—219,28219,28220,58218,64——
SIXT
Technology
SIXT
Technology
SIXT
-0,45%
3 711,69
-16,66
-0,45%
—3 728,353 745,063 745,063 675,02——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,48%
911,05
-4,43
-0,48%
—915,48914,49915,84907,90——
SIXV
Health care
SIXV
Health care
SIXV
+0,22%
1 500,66
+3,30
+0,22%
—1 497,361 500,651 514,701 495,89——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+1,73%
2 454,96
+41,79
+1,73%
—2 413,172 431,692 463,522 431,69——
MGX:NASDAQ
Metagenomi Therapeutics Inc
USD 1,35
-0,74%
(-0,0100) 1D
USD 1,35
0,00% (0,00)
After hours
Closed: 27 Mei, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MGX...
Open
USD 1,33
High
USD 1,42
Low
USD 1,31
Mkt. cap
50,82 m
Avg. vol.
182,05 k
Volume
262,95 k
52-wk high
USD 3,95
52-wk low
USD 1,24
EPS
-USD 2,30
Shares outstanding
37,65 m
No. of employees
118
News stories
From sources across the web
About Metagenomi Therapeutics Inc
CEO-
Employees118
Founded2016
HeadquartersEmeryville, Kalifornië, Verenigde State van Amerika
Sector-
Websitemetagenomi.co
Last report
11 Mei 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-USD 0,61 / -USD 0,55
-10,91%miss
Revenue / Est. (USD)
1,25 m / 5,92 m
-78,94%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
8,51 m
8,66 m
3,91 m
1,25 m
Cost of goods sold
22,51 m
25,28 m
21,50 m
-
Cost of revenue
22,51 m
25,28 m
21,50 m
-
Research and development expenses
-
-
-
19,30 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,99 m
6,22 m
6,78 m
6,54 m
Operating expense
6,99 m
6,22 m
6,78 m
25,84 m
Total operating expenses
29,50 m
31,50 m
28,28 m
25,84 m
Operating income
-20,99 m
-22,84 m
-24,37 m
-24,59 m
Other non operating income
-70,00 k
-2,00 k
-11,00 k
-1,00 k
EBT including unusual items
-19,86 m
-20,63 m
-22,49 m
-23,05 m
EBT excluding unusual items
-18,57 m
-20,63 m
-22,49 m
-23,05 m
Income tax expense
44,00 k
-234,00 k
34,00 k
10,00 k
Effective tax rate
-0,22%
1,13%
-0,15%
-0,04%
Other operating expenses
-
-
-
-
Net income
-19,91 m
-20,39 m
-22,53 m
-23,06 m
Net profit margin
-233,85%
-235,51%
-576,02%
-1 847,68%
Earnings per share
-0,54
-0,55
-0,60
-0,61
Interest and investment income
2,48 m
2,21 m
1,88 m
1,54 m
Interest expense
-
-
-
-
Net interest expenses
2,48 m
2,21 m
1,88 m
1,54 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-19,65 m
-21,52 m
-23,07 m
-23,31 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer